Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product name | Trilostane | Manufacture date | Mar.09.2025 |
Batch number | SW250309 | Analysis date | Mar.10.2025 |
Batch quantity | 500kg | Expiry date | Mar.09.2027 |
Items | Specification | Results |
Appearance | White to off-white Powder | Complies |
Solubility | DMSO: ≥17mg/mL | Complies |
Odor | Odorless | Odorless |
Melting point | 264 °C | 264 °C |
Particle size | 80 mesh | 80 mesh |
Moisture | ≤10.5% | Complies |
Identification |
|
Complies Complies Complies |
Residue on ignition | ≤0.1% | 0.02% |
Compound D | ≤0.1% | 0.04% |
Chromatographic purity TLC max single inpurity |
≤0.4% | 0.11% |
Assay | ≥99% | 99.80% |
Packing description: | Sealed export grade drum & double of sealed plastic bag |
Storage: | Store in cool & dry place not freeze., keep away from strong light and heat |
Shelf life: | 2 years when properly stored |
Similiar product recommendation | |||
Capecitabine | Everolimus | Afatinib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Cediranib |
Cabozantinib | Selumetinib | Cetilistat | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Ponatinib |